Trends in Chronic Diseases Reported by Refugees Originating from Burma Resettling to the United States from Camps Versus Urban Areas During 2009-2016.
Camps and urban settings
Chronic conditions
Refugees originating from Burma
Resettling
Journal
Journal of immigrant and minority health
ISSN: 1557-1920
Titre abrégé: J Immigr Minor Health
Pays: United States
ID NLM: 101256527
Informations de publication
Date de publication:
Apr 2019
Apr 2019
Historique:
pubmed:
16
5
2018
medline:
21
11
2019
entrez:
16
5
2018
Statut:
ppublish
Résumé
We examined changes in the prevalence of chronic health conditions among US-bound refugees originating from Burma resettling over 8 years by the type of living arrangement before resettlement, either in camps (Thailand) or in urban areas (Malaysia). Using data from the required overseas medical exam for 73,251 adult (≥ 18 years) refugees originating from Burma resettling to the United States during 2009-2016, we assessed average annual percent change (AAPC) in proportion ≥ 45 years and age- and sex-standardized prevalence of obesity, diabetes, hypertension, chronic obstructive pulmonary disease (COPD), and musculoskeletal disease, by camps versus urban areas. Compared with refugees resettling from camps, those coming from urban settings had higher prevalence of obesity (mean 18.0 vs. 5.9%), diabetes (mean 6.5 vs. 0.8%), and hypertension (mean 12.7 vs. 8.1%). Compared with those resettling from camps, those from urban areas saw greater increases in the proportion with COPD (AAPC: 109.4 vs. 9.9) and musculoskeletal disease (AAPC: 34.6 vs. 1.6). Chronic conditions and their related risk factors increased among refugees originating from Burma resettling to the United States whether they had lived in camps or in urban areas, though the prevalence of such conditions was higher among refugees who had lived in urban settings.
Identifiants
pubmed: 29761353
doi: 10.1007/s10903-018-0749-y
pii: 10.1007/s10903-018-0749-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
246-256Références
Lancet. 1999 Jun 19;353(9170):2093-9
pubmed: 10382692
Croat Med J. 2002 Apr;43(2):184-9
pubmed: 11885045
AIDS. 2003 Nov 21;17(17):2479-86
pubmed: 14600519
Lancet. 2004 Jan 10;363(9403):157-63
pubmed: 14726171
Lancet Infect Dis. 2009 Dec;9(12):737-46
pubmed: 19926034
Best Pract Res Clin Endocrinol Metab. 2011 Jun;25(3):469-78
pubmed: 21663840
Diabetes Care. 2011 Aug;34(8):1791-3
pubmed: 21715521
JAMA. 2012 Aug 15;308(7):673-4
pubmed: 22893161
MMWR Surveill Summ. 2013 Nov 15;62(7):1-20
pubmed: 24225411
Global Health. 2014 Apr 03;10:24
pubmed: 24708876
Lancet Diabetes Endocrinol. 2017 Jun;5(6):457-468
pubmed: 27499355
Lancet. 2017 Mar 4;389(10072):951-963
pubmed: 28271846
West J Med. 1984 Nov;141(5):691-4
pubmed: 6516349
Am Rev Respir Dis. 1982 Jan;125(1):23-7
pubmed: 7039435